These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 23364622

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comment on the question 'Are the aims of the K/DOQI guidelines for mineral metabolism disorders in stages 3-5 chronic kidney disease unachievable or inadequate?
    Negri AL.
    Nefrologia; 2013; 33(3):424. PubMed ID: 23712231
    [No Abstract] [Full Text] [Related]

  • 6. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH, Quarles LD, Chertow GM.
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [Abstract] [Full Text] [Related]

  • 9. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M, Shahapuni I, Oprisiu R, El Esper N, Morinière P, Massy Z, Choukroun G, Fournier A.
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [Abstract] [Full Text] [Related]

  • 10. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
    Shastri J, Tran A, Covit A, Pepe J, Sherman RA.
    J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
    [Abstract] [Full Text] [Related]

  • 11. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 12. Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.
    Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Baños A, Zani V, Fouque D.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2852-9. PubMed ID: 19369690
    [Abstract] [Full Text] [Related]

  • 13. [Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey].
    Bover J, Górriz JL, Martín de Francisco AL, Caravaca F, Barril G, Molinero LM, Grupo de Estudio OSERCE de la Sociedad Española de Nefrología.
    Nefrologia; 2008 Sep; 28(6):637-43. PubMed ID: 19016638
    [Abstract] [Full Text] [Related]

  • 14. How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.
    Fukagawa M, Akizawa T.
    Ther Apher Dial; 2005 Feb; 9(1):1-2. PubMed ID: 15828896
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W, Chaiyakum A, Pongskul C.
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of bone mineral content in patients with chronic renal failure.
    Gava A, Zorzetto M, Coghetto F, Teodori T, Marazzato G.
    Rays; 1986 Oct; 11(3):67-70. PubMed ID: 3602467
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions.
    Patel TV, Singh AK.
    Semin Nephrol; 2009 Mar; 29(2):105-12. PubMed ID: 19371801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.